Methods: According to the Rapid Guide for Drug Evaluation and Selection in Chinese Medical Institutions (Second Edition) released in 2023, relevant databases such as PubMed, Cochrane, and Embase, drug labels, and clinical guidelines were searched for drug information
Patient volumes for GLP-1s more than tripled between Q1 2020 and Q3 2022, yet only 57.0% of these patients had an official type 2 diabetes diagnosis
What makes tirzepatide different from earlier medications in this class is that it doesnt just target one hormone pathway, it targets two: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
Username or Email Return to Sign in
Nh thuc Vit hy vng bi vit trn gip bn gii p c cu hi Ung Glutathione bao lu th trng v bit cch s dng hiu qu
Therapetuic potential of glucagon-like peptide 1 in type 2 diabetes Diabetic Med 1996 13 : S39S43